Ciliary neurotrophic factor


Ciliary neurotrophic factor
Ciliary neurotrophic factor

PDB rendering based on 1cnt.
Identifiers
Symbols CNTF; HCNTF
External IDs OMIM118945 MGI88439 HomoloGene8288 GeneCards: CNTF Gene
RNA expression pattern
PBB GE CNTF 208597 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 1270 12803
Ensembl ENSG00000242689 ENSMUSG00000079415
UniProt P26441 n/a
RefSeq (mRNA) NM_000614.3 NM_170786.2
RefSeq (protein) NP_000605.1 NP_740756.1
Location (UCSC) Chr 11:
58.39 – 58.39 Mb
Chr 19:
12.84 – 12.84 Mb
PubMed search [1] [2]

Ciliary neurotrophic factor is a protein that in humans is encoded by the CNTF gene.[1][2][3]

The protein encoded by this gene is a polypeptide hormone and nerve growth factor whose actions have mainly been studied in the nervous system where it promotes neurotransmitter synthesis and neurite outgrowth in certain neuronal populations including astrocytes. The protein is a potent survival factor for neurons and oligodendrocytes and may be relevant in reducing tissue destruction during inflammatory attacks. A mutation in this gene, which results in aberrant splicing, leads to ciliary neurotrophic factor deficiency, but this phenotype is not causally related to neurologic disease. In addition to the predominant monocistronic transcript originating from this locus, the gene is also co-transcribed with the upstream ZFP91 gene. Co-transcription from the two loci results in a transcript that contains a complete coding region for the zinc finger protein but lacks a complete coding region for ciliary neurotrophic factor.[3] CNTF has also been shown to be expressed by cells on the bone surface, and to reduce the activity of bone forming cells, osteoblasts.[4]

Contents

Therapeutic applications

Satiety effects

In 2001, it was reported that in a human study examining the usefulness of CNTF for treatment of motor neuron disease, CNTF produced an unexpected and substantial weight loss in the study subjects. Further investigation revealed that CNTF could reduce food intake without causing hunger or stress, making it a candidate for weight control in leptin resistant subjects, as CNTF is believed to operate like leptin, but by a non-leptin pathway.[5]

Axokine

Axokine is a modified version of human Ciliary neurotrophic factor with a 15 amino acid truncation of the C terminus and two amino acid substitutions, which is three to five times more potent than CNTF in in vitro and in vivo assays and has improved stability properties.[6] Like CNTF it is a neurotrophic factor, and may stimulate nerve cells to survive. It was tested in the 1990s as a treatment for amyotrophic lateral sclerosis. It did not improve muscle control as much as expected, but trial participants did report a loss of appetite.

Phase III clinical trials for the drug against obesity were conducted in 2003 by Axokine's maker, Regeneron, demonstrating a small positive effect in some patients, but the drug was not commercialized. A major problem with the treatment was that in nearly 70% of the subjects tested, antibodies against Axokine were produced after approximately three months of treatment.[7] In the minority of subjects who did not develop the antibodies, weight loss averaged 12.5 pounds in one year, versus 4.5 pounds for placebo-treated subjects. In order to obtain this benefit, subjects needed to receive daily subcutaneous injections of one microgram Axokine per kilogram body weight.

Xencor patent application raises the disturbing idea that subjects producing antibodies against CNTF analogues may eventually suffer severe side effects, as these antibodies could potentially interfere with the neuroprotective functions of endogenous CNTF.[8] The application claims methods of designing CNTF analogues with lower immunogenicity than Axokine based on analysis of affinity of each modified epitope for each of 52 class II MHC alleles, and provides specific examples of such modifications. No such analogues are currently listed in Xencor's product pipeline.[9]

NT-501

NT-501 is a product being developed by Neurotech that consists of encapsulated human cells genetically modified to secrete ciliary neurotrophic factor (CNTF). In a clinical trial, NT-501 demonstrated a statistically significant reduction of photoreceptor degradation in patients with retinitis pigmentosa.[10][11]

Interactions

Ciliary neurotrophic factor has been shown to interact with Interleukin-6 receptor.[12][13]

See also

References

  1. ^ Lam A, Fuller F, Miller J, Kloss J, Manthorpe M, Varon S, Cordell B (Sep 1991). "Sequence and structural organization of the human gene encoding ciliary neurotrophic factor". Gene 102 (2): 271–6. doi:10.1016/0378-1119(91)90089-T. PMID 1840538. 
  2. ^ Bazan JF (Sep 1991). "Neuropoietic cytokines in the hematopoietic fold". Neuron 7 (2): 197–208. doi:10.1016/0896-6273(91)90258-2. PMID 1714745. 
  3. ^ a b "Entrez Gene: CNTF ciliary neurotrophic factor". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1270. 
  4. ^ McGregor NE, Poulton IJ, Walker EC, Pompolo S, Quinn JM, Martin TJ, Sims NA (Mar 2010). "Ciliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodeling". Calcified Tissue International 86 (3): 261–70. doi:10.1007/s00223-010-9337-4. PMID 20157807. 
  5. ^ Lambert PD, Anderson KD, Sleeman MW, Wong V, Tan J, Hijarunguru A, Corcoran TL, Murray JD, Thabet KE, Yancopoulos GD, Wiegand SJ (2001). "Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity". Proc. Natl. Acad. Sci. U.S.A. 98 (8): 4652–7. doi:10.1073/pnas.061034298. PMC 31889. PMID 11259650. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=31889. 
  6. ^ Peterson WM, Wang Q, Tzekova R, Wiegand SJ (June 2000). "Ciliary neurotrophic factor and stress stimuli activate the Jak-STAT pathway in retinal neurons and glia". J. Neurosci. 20 (11): 4081–90. PMID 10818143. 
  7. ^ "Axokine from Regeneron (REGN): Unexpected Antibodies and Modest Efficacy in Phase III Study". Press Release. Regeneron Pharmaceuticals. 2003-03-31. http://www.pharmagon.com/Library/InfoManage/Zoom.asp?InfoID=1813&RedirectPath=Add&FolderID=1561&InfoGroup=Main&InfoType=Article. Retrieved 2011-08-20. 
  8. ^ US application 2005064555, Marshall S, Barbosa M, "Ciliary neurotrophic factor variants", published 2005-03-24 
  9. ^ "Product Pipeline". Xencor. http://www.xencor.com/products/pipeline/. Retrieved 2011-08-20. 
  10. ^ Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Lujan BJ, Tao W, Porco TC, Roorda A, Duncan JL (April 2011). "Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment". Invest. Ophthalmol. Vis. Sci. 52 (5): 2219–26. doi:10.1167/iovs.10-6479. PMID 21087953. 
  11. ^ "Neurotech’s NT-501 Implant Demonstrates Statistically Significant Photoreceptor Preservation in Patients with Retinal Degenerative Disease |". Business Wire. 2011-04-11. http://www.businesswire.com/news/home/20110414005343/en/Neurotech’s-NT-501-Implant-Demonstrates-Statistically-Significant-Photoreceptor. Retrieved 2011-08-20. 
  12. ^ Schuster B, Kovaleva M, Sun Y, Regenhard P, Matthews V, Grötzinger J, Rose-John S, Kallen KJ (March 2003). "Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF". J. Biol. Chem. 278 (11): 9528–35. doi:10.1074/jbc.M210044200. PMID 12643274. 
  13. ^ Schooltink H, Stoyan T, Roeb E, Heinrich PC, Rose-John S (December 1992). "Ciliary neurotrophic factor induces acute-phase protein expression in hepatocytes". FEBS Lett. 314 (3): 280–4. doi:10.1016/0014-5793(92)81489-9. PMID 1281789. 

Further reading

External links


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • ciliary neurotrophic factor — (= CNTF) Neurotrophin originally characterized as a survival factor for chick ciliary neurons in vitro. Subsequently shown to promote the survival of a variety of other neuronal cell types, and to promote the differentiation of bipotential O 2A… …   Dictionary of molecular biology

  • Ciliary neurotrophic factor receptor — Identifiers Symbol CNTFR Entrez 1271 HUGO …   Wikipedia

  • Leukemia inhibitory factor receptor — LIFR also known as CD118 (Cluster of Differentiation 118), is a subunit of a receptor for leukemia inhibitory factor. PBB Summary section title = summary text = The leukemia inhibitory factor is a polyfunctional cytokine that affects the… …   Wikipedia

  • Low-affinity nerve growth factor receptor — P75 redirects here. For the New Testament manuscript, see Papyrus 75. For Pentium processor at 75 MHz, see Intel P5 (microarchitecture). Nerve growth factor receptor PDB rendering based on 1sg1 …   Wikipedia

  • Nerve growth factor receptor — Nerve growth factor receptors are a group of growth factor receptors which specifically bind to neurotrophins. There are two classes of receptors, p75 and the Trk family of Tyrosine kinases receptors. p75 is a low affinity neurotrophin receptor,… …   Wikipedia

  • Epidermal growth factor receptor — This article is about a cell surface receptor. For estimated measure of kidney function (eGFR), see Glomerular filtration rate. Epidermal growth factor receptor …   Wikipedia

  • Platelet-derived growth factor receptor — platelet derived growth factor receptor, alpha polypeptide Identifiers Symbol PDGFRA Entrez 5156 HUGO …   Wikipedia

  • leukaemia inhibitory factor — Polypeptide growth factor or cytokine with wide range of activities. Regulates growth and differentiation of primordial germ cells and embryonic stem cells but has effects on peripheral neurons, osteoblasts, adipocytes and various cells of the… …   Dictionary of molecular biology

  • TrkB receptor — Neurotrophic tyrosine kinase, receptor, type 2 PDB rendering based on 1hcf …   Wikipedia

  • TrkA receptor — Neurotrophic tyrosine kinase, receptor, type 1 PDB rendering based on 1he7 …   Wikipedia